Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The most common type of medication for postpartum depression is antidepressants. These drugs can help relieve many of the symptoms of depression, but they take time — typically 6 to 8 weeks ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

One of the most common symptoms of depression in children ... have lasting therapeutic value. Are antidepressant drugs safe for children? Few mental health topics have inspired as much controversy ...